Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL

Sibold William John sold 2,500 Madrigal Pharmaceuticals, Inc. shares (Form 4)

Traded Jul 17 to Jul 20, 2026 · Filed Jul 20, 2026

From Jul 17 to Jul 20, 2026, Sibold William John (Director, President and CEO) sold 2,500 Madrigal Pharmaceuticals, Inc. shares at an average US$547.30 for US$1.37M, leaving 209,329 shares. Filed Jul 20, 2026 (Form 4).

Sold
2,500 shares
Price
US$547.30 average (US$542.75 to US$555.05)
Value
US$1.37M
Holding after
209,329 shares
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 17, 2026Common StockOption exercise50,000211,829Direct
Jul 20, 2026Common StockSale140US$542.75211,689Direct
Jul 20, 2026Common StockSale110US$543.79211,579Direct
Jul 20, 2026Common StockSale545US$544.71211,034Direct
Jul 20, 2026Common StockSale275US$545.71210,759Direct
Jul 20, 2026Common StockSale269US$547.08210,490Direct
Jul 20, 2026Common StockSale680US$547.70209,810Direct
Jul 20, 2026Common StockSale47US$548.87209,763Direct
Jul 20, 2026Common StockSale153US$550.01209,610Direct
Jul 20, 2026Common StockSale1US$550.72209,609Direct
Jul 20, 2026Common StockSale280US$555.05209,329Direct

Source

View original at SEC

Related